Pacific Heights Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-60,000
Closed -$3.79M 80
2020
Q3
$3.79M Hold
60,000
0.49% 54
2020
Q2
$4.62M Sell
60,000
-20,000
-25% -$1.53M 0.69% 45
2020
Q1
$5.87M Hold
80,000
0.99% 34
2019
Q4
$5.2M Sell
80,000
-5,000
-6% -$326K 0.65% 53
2019
Q3
$5.39M Sell
85,000
-2,000
-2% -$131K 0.73% 48
2019
Q2
$5.88M Hold
87,000
0.76% 42
2019
Q1
$5.66M Sell
87,000
-20,000
-19% -$1.33M 0.74% 50
2018
Q4
$6.69M Hold
107,000
0.91% 38
2018
Q3
$8.26M Hold
107,000
0.91% 41
2018
Q2
$7.58M Hold
107,000
0.78% 47
2018
Q1
$8.07M Hold
107,000
0.86% 43
2017
Q4
$7.67M Hold
107,000
0.75% 47
2017
Q3
$8.67M Hold
107,000
0.83% 42
2017
Q2
$7.57M Hold
107,000
0.72% 50
2017
Q1
$7.27M Hold
107,000
0.69% 50
2016
Q4
$7.66M Sell
107,000
-1,000
-0.9% -$74.3K 0.72% 51
2016
Q3
$8.54M Hold
108,000
0.75% 51
2016
Q2
$9.01M Sell
108,000
-2,000
-2% -$177K 0.82% 47
2016
Q1
$10.1M Sell
110,000
-1,000
-0.9% -$90.2K 0.97% 44
2015
Q4
$11.2M Sell
111,000
-29,000
-21% -$3.02M 1.14% 37
2015
Q3
$13.7M Sell
140,000
-80,000
-36% -$8.89M 1.09% 32
2015
Q2
$25.8M Sell
220,000
-30,000
-12% -$3.28M 1.72% 13
2015
Q1
$24.5M Sell
250,000
-25,000
-9% -$2.54M 1.39% 28
2014
Q4
$25.9M Sell
275,000
-150,000
-35% -$15.5M 1.36% 25
2014
Q3
$45.2M Sell
425,000
-100,000
-19% -$9.79M 1.81% 11
2014
Q2
$43.5M Hold
525,000
1.58% 13
2014
Q1
$37.2M Buy
525,000
+3,000
+0.6% +$235K 1.28% 27
2013
Q4
$39.2M Sell
522,000
-300,000
-36% -$20.9M 1.17% 44
2013
Q3
$51.7M Sell
822,000
-402,000
-33% -$24M 1.41% 27
2013
Q2
$62.7M Buy
+1,224,000
New +$63.8M 1.52% 25

Other funds holding GILD

Pacific Heights Asset Management's GILD Position: Q4 2020 in Review

Pacific Heights Asset Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 60,000 shares — an estimated $3.79M sold.

Pacific Heights Asset Management first reported a position in GILD in Q2 2013 and held it in 30 quarters. The position peaked at $62.7M in Q2 2013. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Pacific Heights Asset Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Pacific Heights Asset Management sold 60,000 Gilead Sciences shares in Q4 2020, an estimated $3.79M.
  • Pacific Heights Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 30 quarters.
  • Pacific Heights Asset Management's Gilead Sciences position peaked at $62.7M in Q2 2013.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Pacific Heights Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.